Trial intelligence / Profile preview

Monofer vs RBC Transfusion in Severe Postpartum Iron Deficiency Anaemia

NCT01895205Phase 3Completed

Sponsor
Pharmacosmos
Start
Jun 2013
Primary completion
Aug 2015
Modality
Inorganic Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ferric derisomaltose in iron deficiency anemia (IDA), sponsored by Pharmacosmos. Started Jun 2013; status: completed.

02

Drugs

ferric derisomaltose
03

Conditions

iron deficiency anemia (IDA)

Beyond the preview

Go deeper on NCT01895205.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01895205.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call